These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1971591)

  • 1. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
    Timewell RM; Stark RD; Marlow HF
    Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
    Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
    Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in exercise tolerance and resting haemodynamics during long-term treatment of heart failure with xamoterol.
    Kayanakis JG; Courtault L; Fauvel JM; Boundhoure JP; Snow HM
    Eur Heart J; 1990 Apr; 11 Suppl A():52-3. PubMed ID: 2140552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
    Klein W; Eber B; Rotman B
    Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
    Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R
    Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
    Marlow HF
    Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.
    Cheron P; Nannan M; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():46-7. PubMed ID: 1971589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xamoterol versus digoxin in heart failure.
    Lancet; 1988 Apr; 1(8590):877. PubMed ID: 2895376
    [No Abstract]   [Full Text] [Related]  

  • 13. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
    Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is xamoterol safe in chronic airflow obstruction?
    Roberts JA; Challenor VF; Waller DG
    Eur J Clin Pharmacol; 1992; 42(2):147-50. PubMed ID: 1352245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
    European 'Corwin' Study Group
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term studies with xamoterol in heart failure.
    Waller DG
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xamoterol improves the control of chronic atrial fibrillation in elderly patients.
    Lawson-Matthew PJ; McLean KA; Dent M; Austin CA; Channer KS
    Age Ageing; 1995 Jul; 24(4):321-5. PubMed ID: 7484490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
    Vigholt-Sørensen E; Faergeman O; Snow HM
    Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
    Marlow HF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.